Expanding the spectrum of monoclonal light chain deposition disease in muscle

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Introduction: The diagnosis of amyloid myopathy is delayed when monoclonal gammopathies are not detected on initial testing and muscle biopsies are nondiagnostic, and the EMG and symptoms can mimic an inflammatory myopathy. Methods: Case report of a patient presenting with severe progressive muscle weakness of unclear etiology despite an extensive workup including two nondiagnostic muscle biopsies. Results: Directed by MRI, a third biopsy revealed amyloid angiopathy and noncongophilic kappa light chain deposition in scattered subsarcolemmal rings and perimysial regions. A serum free light chain (FLC) assay revealed a kappa monoclonal gammopathy, which was not detected by multiple immunofixations. Conclusions: The spectrum of immunoglobulin deposition in muscle is similar to other organs. It comprises a continuum that includes parenchymal amyloid deposition, amyloid angiopathy, and noncongophilic Light Chain Deposition Disease (LCDD). We recommend including the FLC assay in the routine investigation for monoclonal gammopathies. This case also highlights the value of MRI-guided muscle biopsy.

Original languageEnglish (US)
Pages (from-to)755-761
Number of pages7
JournalMuscle and Nerve
Issue number5
StatePublished - May 2012
Externally publishedYes


  • Amyloid
  • Gammopathy
  • Light chain deposition
  • MRI
  • Myopathy

ASJC Scopus subject areas

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)


Dive into the research topics of 'Expanding the spectrum of monoclonal light chain deposition disease in muscle'. Together they form a unique fingerprint.

Cite this